Summary. The 
Introduction
Hypoxanthine is a purine derived from the deribosylation of inosine and is a normal component of human serum. Concentrations similar to those found in serum are included in some culture media designed to support serum-free cell growth in vitro, such as (Ham, 1962) . Hypoxanthine blocked the development of some strains of mouse embryos undergoing culture from the early 2-cell stage (Loutradis et ai, 1987) . Embryos from random-bred (CD1) females, but not hybrid-inbred (B6D2F1) females, were arrested from further cleavage in the presence of as little as 6 µ -hypoxanthine. The development block was reversible, however, since embryos transferred into hypoxanthine-free medium resumed development.
The profound, reversible effect of hypoxanthine on the development of mouse 2-cell embryos is of interest for several reasons, one of which is the possibility of a relationship with the previouslyIn addition, hypoxanthine has been shown to play a significant role in the maintenance of meiotic arrest in vivo and in vitro (Downs et ai, 1985 (Downs et ai, , 1986 . A mechanism proposed for the hypoxanthine-induced inhibition of meiosis is elevation of oocyte cAMP levels secondary to inhibition of phosphodiesterase (Chasin & Harris, 1976; Downs et ai, 1989) . Reversal ofthe block by specific inhibitors of purine metabolizing enzymes indicate that guanosine and/or xanthine, possible metabolites of hypoxanthine, play a major role in the mechanism controlling germinal vesicle breakdown (Downs et ai, 1986; , in keeping with their effectiveness in inhibiting oocyte phosphodiesterase activity (Downs et ai, 1989) . A similar mechanism blocking the onset of mitosis could be operational during the initial cleavages ofthe mouse embryo, although the three orders of magnitude difference in effective concentrations of hypoxanthine (6 µ to block embryo cleavage versus 3-5 mM to block germinal vesicle breakdown) indicates that the mechanisms are different.
Purine metabolism is a complex scheme of interelated and reversible enzyme reactions involving ribosylations, phosphorylations and ring modifications, which are described as basically two path¬ ways: the purine salvage pathway and the de-novo synthesis pathway. In the de-novo synthesis pathway, guanosine monophosphate (GMP) and adenosine monophosphate (AMP) arise from modifications of inosine monophosphate (IMP) . Each conversion is a two-step reaction catalysed by separate enzymes as shown in Fig. 1 . An increased concentration of hypoxanthine could result in an increase in IMP via the purine salvage pathway (reaction 3, Fig. 1 (EC 6.3.4.4) , Reaction 2 by IMP-dehydrogenase (EC 1.2.1.14) and Reaction 3 by hypoxanthine guanosine phosphoribosyl transferase (EC 2.4.2.8).
The work reported here was undertaken to identify the possible pathways involved in the hypoxanthine-induced cleavage arrest. We first studied the effects of hypoxanthine and other purines on pronuclear-stage embryos from random-bred, inbred and Fl hybrid-inbred mice to determine whether the initial cleavage was also reversibly blocked. We then investigated the possibility that hypoxanthine was inhibiting phosphodiesterase activity in the early embryo by mechanisms analogous to germinal vesicle maintenance (Downs et ai, 1986; Downs et ai, 1989 (Loutradis et ai, 1987; 
Results
Embryo development in hypoxanthine Exposure of zygotes from all strains examined to 30 µ -hypoxanthine 20-22 h after hCG did not inhibit the initial cleavage (Table 1) . Thereafter, more than 75% ofthe embryos from CD1, CF1, SWR, C3H and C3D2F1 females arrested after the first or second cleavage (Tables 1 and 2 ). Embryos from C57BL/6 and DBA females were less sensitive to hypoxanthine: 62% and 43%, respectively, of those that cleaved to 2 cells also developed to morulae (Table 1) . The most hypoxanthine-resistant zygotes (74% to morulae) were recovered from females ofthe Fl hybrid of these strains, B6D2F1. In contrast, development to morulae of zygotes from the other hybrid strain of DBA, C3D2F1, was significantly (P < 005) inhibited by the presence of hypoxanthine (Table 1) . Zygotes from 5 of the 9 strains examined were therefore sensitive to hypoxanthine; embryos from C57BL/6, DBA, their Fl hybrid, B6D2F1, and another Fl hybrid of C57BL/6, B6SJL, were the most resistant of those tested. (3) - (4) + (5) - (6) + (7) - (6) + (5) - (2) + (2) - (4) + (4) - (2) Most of the embryos that developed to morulae also developed to blastocysts, indicating that hypoxanthine has little or no effect on the morula/blastocyst transition. This was also true of morulae from DBA females which did not develop to blastocysts in 96 h with or without purine, but did so by 120 h, in keeping with earlier observations (Biggers, 1971) .
Other purines and embryo development
The addition of 30 µ -inosine or adenosine to the culture medium also inhibited development of zygotes from CD1 and CF1 females ( Table 2 ). The inhibition was not significantly different (P > 005) from that observed in the presence of hypoxanthine. On the other hand, guanosine (30 µ ), did not significantly (P > 005) inhibit development to the morula or blastocyst stage, nor did it reverse the hypoxanthine block.
The inhibition of embryonic development by hypoxanthine, adenosine and inosine was studied over a wide range of concentration. Figure 2 shows that inhibition at 30 µ was similar to that obtained at 30 µ in all three purines studied. However, at 0-3 µ , inosine had no inhibitory effect on development of pronuclear embryos to morulae, whereas both adenosine and hypoxanthine had a significant inhibitory effect at this concentration. Effect of phosphodiesterase inhibitors on embryo development CD-I pronuclear embryos were cultured in the presence of the phosphodiesterase inhibitors, theophylline and l-methyl-3-isobutyl xanthine (IBMX), at 30 µ each. These concentrations were the same as hypoxanthine and sufficient to inhibit the resumption of meiosis as measured by germinal vesicle breakdown (GVBD) . No inhibition of morula development was observed for either compound (Table 3) . Since inhibition of phosphodiesterase would lead to elevated intracellu¬ lar amounts of cAMP, we included the membrane-permeable analogue, dibutyryl cAMP (100 µ ) as a control in these studies, and it also did not significantly (P > 005) inhibit cleavage. In contrast, GVBD was inhibited in the oocyte controls incubated in parallel in the dibutyryl cAMP and IBMX, but was not inhibited by 30 µ -hypoxanthine (Table 3) . Reversibility of purine effects on CD1 embryos To determine whether the purine inhibition was reversible, zygotes were cultured in purinecontaining medium for 24 h, approximately 6 h beyond the period of sensitivity. The resulting embryos were transferred to purine-free culture conditions, and development to morulae and blastocysts scored at 72 h after transfer (Table 4 ). The CD1 pronuclear embryos exposed for 24 h to hypoxanthine, adenosine, or inosine, respectively, subsequently developed to blastocysts after transfer to purine-free medium, indicating that under these conditions the inhibitory effects of these purines are reversible. Inhibitors of purine metabolic pathways and CD1 embryo development The lack of inhibition of cleavage by guanosine was in contrast to the guanosine arrest of meiosis (Downs et ai, 1985) . This prompted us to investigate further whether the hypoxanthine inhibition was related to elevated guanosine amounts. Bredinin (Sakaguchi et ai, 1975) and mycophenolic acid (Franklin & Cook, 1969) , inhibitors of enzymes in the pathway IMP to GMP (Reaction 2, Fig. 1 (Fig. 1) . To test this possibility, we attempted to block the conversion of IMP to AMP with the antibiotic hadacidin, an inhibitor of adenylate succinate synthetase (Shigeura & Gordon, 1962) . Hadacidin alone at 30 µ did not block morulae formation (56%) by 2-cell CF1 embryos, or modify the hypoxanthine inhibition (8% to morulae in the presence of hadacidin and hypoxanthine).
DNA synthesis
To determine whether the purine inhibition affected the DNA synthesis (S) phase of the cell cycle, embryos from CD1 females cultured with or without hypoxanthine were incubated with
[3H]thymidine added at 30 h (late pronuclear stage) or 40 h (mid 2-cell stage) after hCG The 2-cell embryos that cleaved in the presence or absence of hypoxanthine incorporated equally the radiolabelled thymidine that was added at the late pronuclear stage; similarly, the 4-cell embryos that cleaved with or without hypoxanthine also incorporated equally the thymidine added at the mid 2-cell stage. The purine-induced block is, therefore, inhibiting a process that follows the onset of DNA replication.
Discussion
The results described here confirm and extend previous studies of the hypoxanthine sensitivity of early 2-cell mouse embryos (Loutradis et ai, 1987) . The first cleavage of zygotes exposed to purines approximately 12 h after fertilization (22-24 h after hCG) was not inhibited in any ofthe strains examined. The sensitivity of subsequent cleavages was not restricted to random-bred embryos, but was also observed in some inbred and hybrid-inbred strains of mice. The developmental arrest was most often at the 2-cell stage, although some embryos progressed to the 4-cell stage. This pattern of developmental blockage is similar to that reported for the 'two-cell block' (Goddard & Pratt, 1983) . The period of hypoxanthine sensitivity up to at least 40 h after hCG (Loutradis et ai, 1987 ) is similar, although possibly somewhat prolonged relative to the period of 'two cell block' sensitivity (32 h after hCG: Goddard & Pratt, 1983) .
In keeping with our earlier findings, the paternal component ofthe zygote did not influence the hypoxanthine sensitivity of the embryos since all females were mated with hybrid-inbred males (B6D2F1). Embryos from C57BL/6 mothers were the most resistant of the inbred strains to hypoxanthine inhibition, followed by embryos from DBA mothers. Embryos from F-l hybrids of C57BL/6 (B6D2F1 and B6SJL) were relatively unaffected by hypoxanthine, whereas those derived from the Fl hybrid of DBA (C3D2F1) were sensitive. Thus, resistance to hypoxanthine was best conferred by the C57BL/6 mother. The purine sensitivity of embryos derived from several different strains lead us to believe that this phenomenon is targeting a process that plays an important role in early embryonic cleavage.
The hypoxanthine-induced block to meiosis has been suggested as being due to inhibition of phosphodiesterase activity with consequent increases in oocyte cAMP (Downs et ai, 1989) . However, in our studies, neither dibutyryl cAMP nor the phosphodiesterase inhibitors, theo¬ phylline and IBMX, caused a block to cleavage at concentrations that prevented the resumption of meiosis in oocytes. Moreover, concentrations of hypoxanthine that blocked embryonic cleavage were not effective in maintaining oocyte meiosis arrest. This is consistent with the observation that hypoxanthine is two orders of magnitude less effective than IBMX in inhibiting oocyte phospho¬ diesterase (Downs et ai, 1989) . These results show that the cleavage arrest by hypoxanthine is apparently not due to inhibition of phosphodiesterase activity in the early embryos.
We did not investigate higher concentrations of cAMP or IBMX since elevations in cAMP do lead to cleavage arrest. Ten-fold higher concentrations of dibutyryl cAMP and IBMX than we used in these studies resulted in a reversible block to the first cleavage if added during the Gl phase (18 h after hCG) ofthe cell cycle (Poueymirou & Schultz, 1987) . The resulting arrest was accompanied by changes in the patterns of protein phosphorylation that occur during the first cell cycle (Howlett, 1986) , as well as an inhibition of synthesis of a set of proteins whose messenger RNAs are transcribed during the Gl phase ofthe second cell cycle (Poueymirou & Schultz, 1987) . A similar arrest of cleavage following exposure of embryos to X-irradiation 17-24 h after hCG was also accompanied by an inhibition of phosphorylation of this group of proteins (Grinfeld et ai, 1987 (Grinfeld et ai, , 1988 . To determine whether purines may similarly affect proteins during the first cleavage, we are currently investigating the effects of hypoxanthine exposure during the Gl phase ofthe zygote.
We found that similar concentrations of adenosine and inosine, but not guanosine, blocked embryonic development. However, at 0-3 µ , only hypoxanthine and adenosine, but not inosine, were effective. This suggests that either the purines have differential permeability through the cell membrane or that the inhibition is mediated by pathways other than through the conversion of adenosine and hypoxanthine to inosine. Analyses of the possible pathways of hypoxanthine inhibition of oocyte meiosis revealed that the inhibitors of IMP dehydrogenase, mycophenolic acid (10 µ ) and bredinin (100 µ ), effectively reversed the block to germinal vesicle breakdown. In vitro, mycophenolic acid was 10-fold more effective than bredinin in overcoming the block to meiosis but, in vivo, bredinin was more effective (Downs et ai, 1986; . Our attempts to investigate similarly some of the purine pathways involved in the embryonic inhibition revealed no reversal ofthe arrest induced by hypoxanthine at concentrations of mycophenolic acid that did not inhibit cleavage (Hoshi et ai, 1988) . For reasons unknown, early embryonic cleavages were at least an order of magnitude more sensitive to bredinin, and 3 orders of magnitude more sensitive than germinal vesicle breakdown.
Our results therefore show that the purine-induced cleavage arrest differs from the purine inhibition of meiosis in several respects: first, guanosine is at least as effective as hypoxanthine in blocking GVBD but does not inhibit embryonic cleavage; second, phosphodiesterase inhibitors do not inhibit embryonic cleavage under conditions in which they inhibit GVBD; and third, the hypoxanthine arrest of GVBD, but not the arrest of cleavage, was reversed in the presence of the inhibitors of IMP dehydrogenase. Thus, the mechanisms involved in meiosis arrest (Cho et ai, 1974; Wasserman et ai, 1976; Bornslaeger et ai, 1984; Downs et ai, 1989) are apparently different from those involved in the purine-induced arrest of embryo cleavage.
The regulation of purine nucleotide metabolism in mouse embryos has not been well described. The enzyme hypoxanthine guanosine phosphoribosyl transferase, (HGPRT, Reaction 3, Fig. 1 ), which converts hypoxanthine to IMP and thus limits the conversion of hypoxanthine to uric acid, has been studied (Epstein, 1970) . The activity of this enzyme is low at the pronuclear and 2-cell stages but increases steadily with subsequent cleavages to blastocyst formation. Paynton et ai (1988) detected maternal polyadenylated HGPRT mRNA in mature oocytes and show that this message is persistent to the late 2-cell stage, implying that the enzyme is probably translated from maternal message. The low level of activity of HGPRT at these early stages suggests that the conversion of hypoxanthine to IMP is probably limited.
The conversion of IMP to AMP or GMP at different stages of embryonic development has not been well investigated. Our attempt to investigate these two pathways in the hypoxanthine-blocked embryos by the use of inhibitors of IMP-dehydrogenase and adenylosuccinate synthetase (Fig. 1) revealed that bredinin completely blocked morula formation at concentrations as low as 0-5 µ .
This suggests not only that the IMP to GMP pathway is important to early embryonic cleavage, but also that the embryos have an active adenine kinase, an enzyme reported to be responsible for converting bredinin to an active inhibitor of IMP dehydrogenase (Koyama & Tsuji, 1983) . Studies are in progress to measure the effectiveness of guanosine in reversing the bredinin toxicity. Adenosine also blocked embryonic development, although hadacidin failed to reverse the hypoxan¬ thine block and did not inhibit cleavage at the same concentration as hypoxanthine. These results taken together indicate that the metabolic conversions of IMP to AMP or GMP do not play a significant role in the purine-induced block to development, although they may be essential cell processes in the early cleaving embryo.
As shown in Fig. 1 , position 2 in the purine ring is unsubstituted in adenosine, inosine and hypoxanthine. However, the hydrogen atom at position 2 is substituted by an amino group in guanosine and by a carbonyl group in IMBX. These considerations suggest that the inhibition of cleavage beyond the 2-cell stage of hypoxanthine, adenosine and inosine may be due to steric inhibition of an enzyme reaction necessary for further embryonic development that a substitution at position 2 does not allow. Another possibility is interaction with adenosine receptors which have been described in many systems including brain, heart, adipocytes, and testis (Daly, 1985; Wolff et (Boynton & Whitfield, 1983) .
Thymidine incorporation was not blocked in embryos cultured in hypoxanthine. Although the autoradiography studies do not confirm the completion of replication, the lack of inhibition of thymidine uptake suggests that the block to cleavage occurs after the onset of the S phase of the cycle. This is consistent with the cleavage arrest brought about by inhibition of cAMP-dependent protein kinase which also did not inhibit thymidine incorporation, although synthesis of the 'transcription requiring proteins', was inhibited (Poueymirou & Schultz, 1989) . We are currently investigating the effect of purines on the appearance of these proteins.
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